The Role of Sema3D in Cardiac Development
Sema3D 在心脏发育中的作用
基本信息
- 批准号:8698445
- 负责人:
- 金额:$ 13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-26 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAdvisory CommitteesAlkaline PhosphataseAllelesAnimal ModelArrhythmiaArteriesAtrial Heart Septal DefectsBasic ScienceBindingBiochemicalBiochemical PathwayBiological AssayBiological ModelsBiological ProcessBlood VesselsCandidate Disease GeneCardiacCardiologyCardiovascular systemChildChild health careChildhoodClinicalCollaborationsComplexCongenital AbnormalityCongenital Heart DefectsCore FacilityDataDefectDevelopmentDevelopmental BiologyDevelopmental ProcessDiseaseDoctor of MedicineDoctor of PhilosophyEmbryoEmbryonic StructuresEndothelial CellsEnsureEnvironmentEventExonsFacultyGenesGeneticHeartHeart AtriumHistologyHumanImmuneImmunodeficiency and CancerInstitutesK-Series Research Career ProgramsLabelLeft atrial structureLifeLungMediatingMedicineMentorsMentorshipMissense MutationModelingMolecularMolecular BiologyMorbidity - disease rateMusMutagenesisMutant Strains MiceMutationNational Research Service AwardsNeuropilin-1NeuropilinsOpticsPathogenesisPatientsPatternPediatric HospitalsPennsylvaniaPhenotypePhiladelphiaPhysiciansPlant RootsPlatelet-Derived Growth Factor ReceptorPlayPostdoctoral FellowProgram DevelopmentProlineProtein RegionProteinsPublishingPulmonary veinsRegulationReportingResearchResearch SupportResourcesRoleSECTM1 geneScienceScientistSemaphorinsSerineSignal TransductionSignaling MoleculeSiteStenosisStructureStructure of sinus venosus of fetusSystemic venous structureTestingTrainingTraining ProgramsTumor AngiogenesisUniversitiesVariantVenousWorkaxon guidancecareercareer developmentcell motilitycohortcongenital heart disorderdesignembryo tissuegenetic analysisgraduate studenthuman diseasein vitro Assayinsightmortalitymouse modelmutantnervous system disordernovelpediatric departmentplexinprofessorprogramsreceptorresearch studyskillssuccesstomographytooltumor progression
项目摘要
DESCRIPTION (provided by applicant): This proposal describes a five-year training program for development of a research career in cardiovascular developmental biology. The candidate is a clinical associate in pediatric cardiology at the Children's Hospital of Philadelphia (CHOP), with an M.D.-Ph.D. in molecular biology. He has extended his training engaged in intensive basic science research supported by the Ruth L. Kirschstein National Research Service Award (T32), and is currently supported by the Department of Pediatrics Child Health Research Career Development Award (K12). The proposed research will enhance our understanding of congenital heart disease. It will be carried out under the mentorship of Jonathan Epstein, M.D. a recognized leader in the field of cardiac development. He is a professor of Medicine, and the scientific director of the University of Pennsylvania Cardiovascular Institute (CVI). He has mentored numerous Postdoctoral fellows and graduate students. An advisory committee of talented clinician-scientists has been assembled to offer guidance in career development and science. The environment of CHOP and the CVI provides extensive resources, collaborations, core facilities and intellectual expertise. This is an ideal training setting to develop a skill set in order to transition to an independent career as a physician-scientist. Participation in didactic courses and faculty professional development seminars will enhance the educational success of the program. Congenital heart disease (CHD) is the most common life-threatening birth defect in humans. Total or partial anomalous pulmonary venous return (TAPVR or PAPVR) are significant causes of morbidity and mortality in childhood. Moreover, the pulmonary veins are prone to stenosis, which frequently complicates the treatment of patients with TAPVR and other forms of CHD. In addition, the pulmonary veins are a frequent site of origin for atrial arrhythmias in adults, and developmental abnormalities have been proposed to be at the root of such arrhythmias. Despite these clinically compelling conditions, development of the venous pole of the heart is a relatively understudied aspect of cardiovascular development. Semaphorins represent a class of signaling molecules that are critical in various developmental processes, including axon guidance, immune regulation, tumor angiogenesis and vascular patterning. Targeted mutation of Sema3D has results in TAPVR/PAPVR in mice. These mice present a novel tool for investigating the patterning of the pulmonary veins. Sema3D binds to neuropilin-1, and this interaction will be investigated in detail. As global deletion of Sema3D has a robust phenotype in mice, it is an excellent candidate gene for CHD in humans. A Sema3D missense mutation has been found in a patient with TAPVR. The functional impact of this mutation will be investigated and additional genetic analysis of patients is underway. The data obtained in the course of the proposed research will provide insights into normal and abnormal pulmonary venous patterning, semaphorin signaling, and the genetic roots of congenital heart disease.
描述(由申请人提供):该提案描述了一项为期五年的心血管发育生物学研究职业的培训计划。候选人是费城儿童医院(CHOP)的儿科心脏病学临床助理,并拥有M.D.-PH.D.在分子生物学中。他扩大了受到Ruth L. Kirschstein国家研究服务奖(T32)支持的强化基础科学研究的培训,目前得到儿科儿童健康研究职业发展奖(K12)的支持。拟议的研究将增强我们对先天性心脏病的理解。它将在乔纳森·爱泼斯坦(Jonathan Epstein)的指导下进行,医学博士是心脏发展领域公认的领导者。他是医学教授,宾夕法尼亚大学心血管研究所(CVI)的科学主任。他指导了许多博士后研究员和研究生。有才华的临床医生科学家的咨询委员会已经组装,以在职业发展和科学方面提供指导。 CHOP和CVI的环境提供了广泛的资源,合作,核心设施和知识专业知识。这是一个理想的培训设置,可以开发技能,以便过渡到医生科学家的独立职业。参加教学课程和教师专业发展研讨会将增强该计划的教育成功。 先天性心脏病(CHD)是人类中最常见的生命的先天缺陷。总肺静脉回流(TAPVR或PAPVR)是儿童发病率和死亡率的重要原因。此外,肺静脉易于狭窄,这通常使TAPVR和其他形式的CHD患者的治疗复杂化。另外,肺静脉是成人心律不齐的常见原始部位,并且已经提出发育异常是这种心律不齐的根源。尽管有这些临床上令人信服的条件,但心脏静脉的发育是心血管发育的相对研究的方面。 信号蛋白代表一类信号分子,在各种发育过程中至关重要,包括轴突引导,免疫调节,肿瘤血管生成和血管模式。 SEMA3D的靶向突变具有小鼠的TAPVR/PAPVR。这些小鼠提出了一种用于研究肺静脉模式的新工具。 SEMA3D与Neuropilin-1结合,将详细研究这种相互作用。由于SEMA3D的全球缺失在小鼠中具有强大的表型,因此它是人类中冠心病的出色候选基因。在TAPVR患者中发现了SEMA3D错义突变。将研究该突变的功能影响,并正在进行患者的其他遗传分析。在拟议的研究过程中获得的数据将提供有关正常和异常的肺静脉模式,闪存蛋白信号传导以及先天性心脏病的遗传根的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Karl Degenhardt其他文献
Karl Degenhardt的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Karl Degenhardt', 18)}}的其他基金
Genetic and Environmental Modifiers of Congenital Heart Disease
先天性心脏病的遗传和环境因素
- 批准号:
9353842 - 财政年份:2016
- 资助金额:
$ 13万 - 项目类别:
相似海外基金
Mechanisms of Skeletal Morphogenesis During Digit Tip Regeneration
指尖再生过程中骨骼形态发生的机制
- 批准号:
10371285 - 财政年份:2022
- 资助金额:
$ 13万 - 项目类别:
Mechanisms of Skeletal Morphogenesis During Digit Tip Regeneration
指尖再生过程中骨骼形态发生的机制
- 批准号:
10655300 - 财政年份:2022
- 资助金额:
$ 13万 - 项目类别:
TNSALP Mutations in Atypical Femoral Fractures with Long-Term Bisphosphonate Use
长期使用双膦酸盐导致非典型股骨骨折的 TNSALP 突变
- 批准号:
8652438 - 财政年份:2013
- 资助金额:
$ 13万 - 项目类别:
TNSALP Mutations in Atypical Femoral Fractures with Long-Term Bisphosphonate Use
长期使用双膦酸盐导致非典型股骨骨折的 TNSALP 突变
- 批准号:
8426982 - 财政年份:2013
- 资助金额:
$ 13万 - 项目类别: